News | September 10, 2025
Navin Fluorine inaugurates Phase-1 of new cGMP-4 facility of Navin Molecular at Devas
The cGMP-4 facility will further strengthen the company's ability to serve global partners
The cGMP-4 facility will further strengthen the company's ability to serve global partners
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
This is Lupin's first product using proprietary Nanomi's technology and has a 180-day CGT exclusivity
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
Fortis will assume complete operational and financial control, allowing it to consolidate the hospital's performance within its network
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
The sudden subsequent decision to suspend IXCHIQ is based on updated VAERS data
The new lineup includes CereTom Elite, OmniTom Elite, OmniTom Elite PCD, and BodyTom 32/64
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
Subscribe To Our Newsletter & Stay Updated
